63.57 
2.37(3.59%) 4:01PM EDT|After Hours
:
64.17 0.60 (0.94%) 4:49PM EDT
| Prev Close: | 65.94 |
|---|
| Open: | 65.88 |
|---|
| Bid: | 60.17 x 100 |
|---|
| Ask: | 63.88 x 200 |
|---|
| 1y Target Est: | 71.83 |
|---|
| Beta: | 1.02 |
|---|
| Next Earnings Date: | 1-Aug-13 |
|---|
| Day's Range: | 63.54 - 65.90 |
|---|
| 52wk Range: | 50.40 - 68.83 |
|---|
| Volume: | 3,094,768 |
|---|
| Avg Vol (3m): | 2,693,870 |
|---|
| Market Cap: | 29.91B |
|---|
| P/E (ttm): | 16.52 |
|---|
| EPS (ttm): | 3.85 |
|---|
| Div & Yield: | 1.04 (1.60%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- COVIDIEN PLC FinancialsEDGAR Online Financials(Tue, Jun 18)
- 4 Stocks Pushing The Health Services Industry Downwardat TheStreet(Tue, Jun 18)
- Covidien plc to Report Third-Quarter Results on August 1, 2013Business Wire(Tue, Jun 18)
- Jim Cramer: Buy Applied Materials, Covidien, and W.R. Grace, But Sell This Stockat Wall St. Cheat Sheet(Mon, Jun 17)
- Positive Data for COV's SolitaireZacks(Mon, Jun 17)
- General Electric Commits to Boeing Purchase and 3 More Hot Stocksat Wall St. Cheat Sheet(Mon, Jun 17)
- InPlay: Covidien Announces Publication of Final Results of Pipeline Embolization Device Pivotal Study; Results show Pipeline device offers safe and effective treatment of large and giant aneurysmsBriefing.com(Mon, Jun 17)
- Covidien Announces Publication of Final Results of Pipeline™ Embolization Device Pivotal StudyBusiness Wire(Mon, Jun 17)
- Is Johnson & Johnson A Buy At These Prices?at Wall St. Cheat Sheet(Sat, Jun 15)
- Cramer's Top Stock Picks: FDX KMX COV GRA USNA CLVSat TheStreet(Sat, Jun 15)
- Cramer's 'Mad Money' Recap: Next Week's Game Planat TheStreet(Fri, Jun 14)
- Cramer: This Break-Up Creating Immense Valueat CNBC(Fri, Jun 14)
- [video] A Breakup Play to Change Your Tuneat CNBC(Fri, Jun 14)
- Covidien Announces Effectiveness of Mallinckrodt Form 10 Registration StatementBusiness Wire(Thu, Jun 13)
- Bear Of The Day: Covidienat Seeking Alpha(Wed, Jun 12)
Key Statistics
| Forward P/E (1 yr): | 15.36 |
|---|
| P/S (ttm): | 2.55 |
|---|
| Ex-Dividend Date: | 02-Apr-13 |
|---|
Analysts
| Annual EPS Est
(Sep-13)
: | 3.78 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.90 |
|---|
| Mean Recommendation*: | 1.7 |
|---|
| PEG Ratio (5 yr expected): | 2.15 |
|---|
Business Summary
Covidien plc develops, manufactures, and sells healthcare products for use in clinical and home settings worldwide. Its Medical Devices segment offers endomechanical instruments, such as laparoscopic instruments, surgical staplers, and interventio...
View More